NAOMI TRAVERS: Open Payments
NPI 1639550833 · POWAY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,455 in 85 payments from 21 companies in 2025. Trend: 2023 $1,441 · 2024 $2,508 · 2025 $2,455
Food & beverage: $2,355Education: $100
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $283 |
| GENZYME CORPORATION | 4 | $265 |
| Janssen Biotech, Inc. | 10 | $250 |
| ABBVIE INC. | 12 | $249 |
| Incyte Corporation | 3 | $187 |
| LEO Pharma Inc. | 9 | $172 |
| Regeneron Pharmaceuticals, Inc. | 1 | $149 |
| Galderma Laboratories, L.P. | 5 | $143 |
| Janssen Scientific Affairs, LLC | 1 | $138 |
| Novartis Pharmaceuticals Corporation | 6 | $131 |
Products named: TREMFYA, DUPIXENT, OPZELURA, ADBRY, LIBTAYO, ILUMYA, RINVOQ, SKYRIZI.
Industry payments across CA — which companies pay providers there.
